88R2337 KKR-D
 
  By: Perry S.B. No. 265
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to required reports of certain vaccine-related or
  drug-related injuries and adverse events.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter A, Chapter 161, Health and Safety
  Code, is amended by adding Section 161.0103 to read as follows:
         Sec. 161.0103.  REQUIRED REPORT OF CERTAIN VACCINE-RELATED
  INJURIES AND ADVERSE EVENTS.  (a)  This section applies only to a
  vaccine that is:
               (1)  experimental or investigational; or
               (2)  approved or authorized for emergency use by the
  United States Food and Drug Administration.
         (b)  Notwithstanding any other law, for a vaccine to which
  this section applies a physician shall report to the federal
  Vaccine Adverse Event Reporting System:
               (1)  each potential vaccine-related injury of a patient
  the physician treats; and
               (2)  any adverse event following the patient's
  vaccination.
         (c)  A physician who violates this section is subject to
  disciplinary action by the Texas Medical Board as if the physician
  violated Subtitle B, Title 3, Occupations Code.
         (d)  The executive commissioner shall adopt rules necessary
  to implement this section.
         SECTION 2.  Subchapter E, Chapter 431, Health and Safety
  Code, is amended by adding Section 431.1145 to read as follows:
         Sec. 431.1145.  REQUIRED REPORT OF CERTAIN DRUG-RELATED
  INJURIES AND ADVERSE EVENTS.  (a)  This section applies only to a
  drug that is:
               (1)  experimental or investigational; or
               (2)  approved or authorized for emergency use by the
  United States Food and Drug Administration.
         (b)  Notwithstanding any other law, for a drug to which this
  section applies a physician shall report to the United States Food
  and Drug Administration through the MedWatch Reporting System:
               (1)  each potential drug-related injury of a patient
  the physician treats; and
               (2)  any adverse event following the administration or
  use of the drug.
         (c)  A physician who violates this section is subject to
  disciplinary action by the Texas Medical Board as if the physician
  violated Subtitle B, Title 3, Occupations Code.
         (d)  The executive commissioner shall adopt rules necessary
  to implement this section.
         SECTION 3.  As soon as practicable after the effective date
  of this Act, the executive commissioner of the Health and Human
  Services Commission shall adopt rules necessary to implement the
  changes in law made by this Act.
         SECTION 4.  This Act takes effect September 1, 2023.